Archive for the ‘Tiens Biotech Group USA Inc. TBV’ Category

Beacon Equity Research Featured Company: Tiens Biotech Group USA, Inc. (TBV)

Friday, December 28th, 2007

Tiens Biotech Group USA, Inc. (TBV) is focused on researching, developing, manufacturing, and marketing high quality nutritional supplements and wellness products around the globe. The Company’s product line includes the High Calcium Series, the Immune Enhancement Series, the Nutrient Supplement Series, the Adjustment Series, the High-Fiber Series, and the Heart and Brain Improvement Series.

The Company operates through two subsidiaries, Tianjin Tianshi Biological Development Co., Ltd. (Biological) and Tiens Yihai Co., Ltd. (Tiens Yihai). Tiens Biotech Group owns an 80% interest in Biological, which offers an array of supplemental products. Tiens Yihai was a subsidiary formed consequently to a joint venture signed between the Company and Tianjin Tianshi Pharmaceutical Co., Ltd, and it is engaged in researching, developing, producing, and marketing nutritional supplement products, home care products, and personal care products.

Demand for dietary supplements in the U.S. is rapidly increasing and has become a multibillion-dollar industry. As of May 2006, the estimated worth of North American vitamins, minerals, and supplement markets totals $17.7 billion. The World Health Organization has estimated that nearly 80% of the population in developing countries depends on natural products for their main health care needs. In fact, in France and Germany 30-40% of all medical doctors are acknowledged for relying on herbal preparations for their primary medicine.

Let us hear your thoughts: Tiens Biotech Group USA, Inc. Message Board